The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Hypertrophic cardiomyopathy and Cardiomyopathy. The concepts of his Internal medicine study are interwoven with issues in Guideline and Surgery. As part of his studies on Cardiology, James E. Udelson often connects relevant subjects like Magnetic resonance imaging.
His Heart failure research incorporates elements of Endocrinology, Afterload and Vasopressin Antagonists. His work on Ventricular outflow tract obstruction as part of general Hypertrophic cardiomyopathy study is frequently linked to Septal myectomy, Alcohol septal ablation and Ventricular Outflow Obstruction, therefore connecting diverse disciplines of science. His Cardiomyopathy research is multidisciplinary, relying on both Basal, Prospective cohort study, Circulatory system, Anterior mitral leaflet and Cohort.
James E. Udelson spends much of his time researching Internal medicine, Cardiology, Heart failure, Ejection fraction and Coronary artery disease. His work on Hypertrophic cardiomyopathy, Myocardial infarction, Randomized controlled trial and Heart disease is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. His research in Cardiology intersects with topics in Magnetic resonance imaging and Radiology.
His Heart failure study combines topics from a wide range of disciplines, such as Placebo, Clinical trial, Vasopressin Antagonists and Intensive care medicine. His Ejection fraction study integrates concerns from other disciplines, such as Asymptomatic and Heart rate. His Coronary artery disease study incorporates themes from Framingham Risk Score, Perfusion and Revascularization.
His primary areas of investigation include Internal medicine, Cardiology, Heart failure, Chest pain and In patient. Myocardial infarction, Coronary artery disease, Randomized controlled trial, Acute coronary syndrome and Hypertrophic cardiomyopathy are among the areas of Internal medicine where James E. Udelson concentrates his study. His work in the fields of Coronary artery disease, such as Myocardial perfusion imaging, intersects with other areas such as CAD.
His study in Cardiology is interdisciplinary in nature, drawing from both Therapeutic effect, Cardiac magnetic resonance imaging and Hazard ratio. His biological study spans a wide range of topics, including Anesthesia, Clinical trial and Intensive care medicine. His Chest pain research is multidisciplinary, incorporating perspectives in Imaging study, Radiology, Cohort and Functional testing.
James E. Udelson mainly focuses on Internal medicine, Cardiology, Heart failure, Myocardial infarction and Chest pain. His Internal medicine research focuses on Coronary artery disease, Randomized controlled trial, Prospective cohort study, Hypertrophic cardiomyopathy and Obstructive hypertrophic cardiomyopathy. In general Cardiology study, his work on Acute coronary syndrome often relates to the realm of In patient, thereby connecting several areas of interest.
His work deals with themes such as Mitral valve, Clinical endpoint and Quality of life, which intersect with Heart failure. The study incorporates disciplines such as Ventricle and Hemodynamics in addition to Myocardial infarction. The various areas that James E. Udelson examines in his Chest pain study include Coronary computed tomography angiography and Radiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Bernard J. Gersh;Barry J. Maron;Robert O. Bonow;Joseph A. Dearani;Joseph A. Dearani.
ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging—Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)
Francis J. Klocke;Michael G. Baird;Beverly H. Lorell;Timothy M. Bateman.
Journal of the American College of Cardiology (2003)
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.
Kevin C Allman;Leslee J Shaw;Rory Hachamovitch;James E Udelson.
Journal of the American College of Cardiology (2002)
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial
Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld.
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Bernard J. Gersh;Barry J. Maron;Robert O. Bonow;Joseph A. Dearani.
Journal of the American College of Cardiology (2011)
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Bernard J. Gersh;Barry J. Maron;Robert O. Bonow;Joseph A. Dearani.
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
Pamela S. Douglas;Udo Hoffmann;Manesh R. Patel;Daniel B. Mark.
The New England Journal of Medicine (2015)
Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude
Jeffrey T Kuvin;Ayan R Patel;Kathleen A Sliney;Natesa G Pandian.
American Heart Journal (2003)
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
Mihai Gheorghiade;Marvin A. Konstam;John C. Burnett;Liliana Grinfeld.
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
M A Konstam;M F Rousseau;M W Kronenberg;J E Udelson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: